The current SBFM market cap is 20.8M. The company's latest EPS is USD -0.1755 and P/E is -4.62.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 133k | 3.94M | 4.89M | 5.56M | 5.96M |
Operating Income | -3.18M | -23.36M | -1.83M | -990k | -779k |
Net Income | -1.46M | -23.51M | -1.7M | -903k | -651k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 21k | 71k | 228k | 4.35M | 24.09M |
Operating Income | -643k | -577k | -2.44M | -27M | -4.79M |
Net Income | -1.66M | -2.78M | -12.44M | -26.74M | -4.51M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 40.86M | 29.24M | 26.99M | 28.41M | 27.65M |
Total Liabilities | 480k | 7.62M | 7.56M | 5.3M | 5.69M |
Total Equity | 40.38M | 21.63M | 19.43M | 23.11M | 21.96M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 98k | 1.05M | 2.2M | 29.24M | 27.35M |
Total Liabilities | 833k | 2M | 1.99M | 7.62M | 6.14M |
Total Equity | -735k | -955k | 212k | 21.63M | 21.21M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3M | -5.25M | -1.85M | -5.63M | -6.09M |
Investing | N/A | -14.62M | -146k | -406k | -387k |
Financing | 41.56M | 39.47M | -538k | 3.52M | 3.46M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -496k | -657k | -1.83M | -5.25M | -8.78M |
Investing | -15k | -1,000 | N/A | -14.62M | -656k |
Financing | 442k | 1.61M | 2.9M | 39.47M | 3.43M |
Market Cap | 20.8M |
Price to Earnings Ratio | -4.62 |
Price to Sales Ratio | 0.86 |
Price to Cash Ratio | 1.28 |
Price to Book Ratio | 0.98 |
Dividend Yield | - |
Shares Outstanding | 25.68M |
Average Volume (1 week) | 7.54M |
Average Volume (1 Month) | 30.13M |
52 Week Change | -98.81% |
52 Week High | 140.00 |
52 Week Low | 0.75 |
Spread (Intraday) | 0.01 (0.62%) |
Company Name | Sunshine Biopharma Inc |
Address |
6500 trans-canada highway 4th floor montreal, quebec H9R 0A5 |
Website | https://www.sunshinebiopharma.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.